Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: United States Clear all

219 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20023
20033
20044
20051
20064
20076
20087
200915
20108
20112
20128
20135
20148
20158
201610
201712
201813
201915
202010
202118
20228
20237
20245
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed117
Terminated40
Recruiting24
Active, not recruiting21
Withdrawn9
Unknown status5
Suspended2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
M.D. Anderson Cancer Center8
Incyte Corporation6
AbbVie5
City of Hope Medical Center5
Abramson Cancer Center at Penn Medicine4
Bayer4
Jonsson Comprehensive Cancer Center4
Massachusetts General Hospital4
Mayo Clinic4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular219
Liver Neoplasms58
Stomach Neoplasms54
Carcinoma, Non-Small-Cell Lung51
Carcinoma, Renal Cell47
Neoplasms43
Melanoma41
Pancreatic Neoplasms41
Breast Neoplasms36
Squamous Cell Carcinoma of Head and Neck33

Trials

Showing 1 to 25 of 219. Each trial links to its page on Pharma Observatory.

119 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.